Male birth control, like death, is always just around the corner. In 2014, the hope was that Vasalgel, a non-hormonal polymer gel that can be injected into the vas deferens, would hit the market by 2017. But the Parsemus Foundation, the non-profit organization funding Vasalgel, has since revised that projection to 2018, pending successful human trials and “public support.”
Tag: Parsemus Foundation
New Male Contraceptive is Expected to Hit the Market in 2017
Aside from having a vasectomy, wearing a condom or simply just abstaining from having sexual intercourse, men do not have many options for birth control. Parsemus Foundation, a group that works on neglected medical research, is working on a male version of the pill named Vasalgel that is expected to hit the market in 2017.
We Might Finally Be Getting A Little Closer to Male Birth Control
A non-hormonal form of male birth control could be available on the U.S. market as soon as 2017, according to the latest update from the Parsemus Foundation, the organization working to develop the contraceptive. While the news is inspiring the latest round of hopeful headlines about the possibility that women soon won’t have to shoulder most of the responsibility for pregnancy prevention, an effective option for men is likely still a long way away.